Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus for Intestinal Polyps in Peutz-Jeghers Syndrome
NCT00811590Phase 2Terminated
- Sponsor
- University of Utah
- Start
- Nov 2008
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of everolimus in Peutz-Jeghers syndrome (PJS), sponsored by University of Utah. Primary endpoint: The Size of Intestinal Polyps at 24 months. Started Nov 2008; status: terminated.
02
Drugs
everolimus
03
Conditions
Peutz-Jeghers syndrome (PJS)
Beyond the preview
Go deeper on NCT00811590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00811590.